New Generation of Meso and Antiprogestins (SPRMs) into the Osteoporosis Approach
Receptor activator of nuclear factor κB (RANK) and its ligand (RANKL) play key roles in bone metabolism and the immune system. The RANK/RANKL complex has also been shown to be critical in the formation of mammary epithelia cells. The female hormones estradiol and progesterone closely control the act...
Enregistré dans:
Auteurs principaux: | Magdalena Woźniczka, Katarzyna Błaszczak-Świątkiewicz |
---|---|
Format: | article |
Langue: | EN |
Publié: |
MDPI AG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/7b10aaf7ac6e4049a35883c746c27a12 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Receptor activator of nuclear factor-κB ligand and osteoprotegerin: maintaining the balance to prevent bone loss
par: Anne-Priscille Trouvin, et autres
Publié: (2010) -
Emerging treatments for postmenopausal osteoporosis – focus on denosumab
par: Piet Geusens
Publié: (2009) -
Comprehensive Transcriptomic Profiling of Murine Osteoclast Differentiation Reveals Novel Differentially Expressed Genes and LncRNAs
par: Salman M. Toor, et autres
Publié: (2021) -
Enfrentamiento de la osteoporosis post menopáusica en la consulta ginecológica
par: Francisco,Fuentes Q, et autres
Publié: (2017) -
Changes in Bone Metabolism and Structure in Primary Hyperparathyroidism
par: Yankova I., et autres
Publié: (2020)